Scientists say study findings indicate that TC IV cells may represent a therapeutic target for the treatment of ...

To address this challenge, CTMC has established a patient material bank, enabling early-stage process development with clinically relevant samples. This resource also supports continuous process ...

BCB-276 has earned regenerative medicine advanced therapy designation from the FDA in diffuse intrinsic pontine glioma, an ...

Rising prevalence, aging populations, and therapeutic innovation are reshaping the landscape of multiple myeloma care and ...

Canadian firm INKAS can take your fourth-generation Tacoma to BR6 protection against 7.62-mm rounds and DM51-style grenade ...

Cancer treatment with a cell-based immunotherapy causes mild cognitive impairment, a Stanford Medicine team found. They also identified compounds that could treat it.

The first CAR-T cell therapy was developed and approved by the FDA in 2017 to treat relapsed or refractory B-cell precursor ...

A next-generation "armored" CAR T cell therapy showed promising results in a small study of patients whose B-cell lymphomas continued to resist multiple rounds of other cancer treatments, including ...

KINGSTON — A groundbreaking innovation in cancer therapy is now available in the Limestone City thanks to the work and ...

A next-generation "armored" CAR T cell therapy showed promising results in a small study of patients whose B-cell lymphomas continued to resist multiple rounds of other cancer treatments, including ...

A next-generation, anti-CD19 enhanced (or "armored") CAR T-cell product showed promising efficacy and safety in a phase I ...